Rubric Capital Management LP
Source: SEC Form 13F · as of Mar 2026Rubric Capital Management LP holds 12 biotech & pharma companies tracked by BioSniper, totaling $829.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$829.9M
| Company | Shares | Value |
|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 15,250,000 | $459.3M |
| ROIVRoivant Sciences Ltd. | 5,000,000 | $138.5M |
| PTGXProtagonist Therapeutics, Inc | 427,998 | $45.1M |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 1,279,611 | $42.3M |
| NRIXNurix Therapeutics, Inc. | 2,473,885 | $38.3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 440,560 | $24.9M |
| INDVIndivior Pharmaceuticals, Inc. | 662,515 | $20.2M |
| ACHCAcadia Healthcare Company Inc. | 850,000 | $19.9M |
| ADMAADMA BIOLOGICS, INC. | 1,809,408 | $16.3M |
| ARDXARDELYX, INC. | 1,860,896 | $11.1M |
| MNKDMANNKIND CORP | 3,620,413 | $8.9M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 691,170 | $5.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.